SR

Sparsh Raghuvanshi

Director Director DIN 03079770
DIN 03079770 First appointment Jun 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2010
Shareholding value •••• Premium profile

About Sparsh Raghuvanshi

Data last updated:

Sparsh Raghuvanshi was a Director at Swega Laboratories Limited (2010–2019) and Director at Gencure Pharmaceuticals Private Limited (2010–2016). The companies operate in Pharma and Chemicals.

DIN 03079770
Primary Designation Director
Industry Pharma
First Appointment 14 Jun 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Swega Laboratories Limited U24231UP1996PLC020829
Director31 Dec 20101996₹7.98 Cr (FY 2024)Active
Director14 Jun 20102009₹1.26 Cr (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Swega Laboratories Limited
Gencure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sparsh Raghuvanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sparsh Raghuvanshi

Sparsh Raghuvanshi was first appointed on 14 Jun 2010 as Director at Gencure Pharmaceuticals Private Limited.

Sparsh Raghuvanshi held 2 earlier board appointments: Swega Laboratories Limited (Director, 31 Dec 2010 to 01 Nov 2019); Gencure Pharmaceuticals Private Limited (Director, 14 Jun 2010 to 11 Apr 2016).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available